Taro Pharmaceutical Industries Ltd. Postpones Shareholders Meetings on Proposed Merger With Sun Pharmaceutical Industries Ltd

Published: Nov 15, 2012

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro”) announced today that it has postponed its extraordinary general meeting of shareholders and the class meeting of holders of ordinary shares, originally scheduled for December 6, 2012, to consider the proposed merger of Taro with a subsidiary of Sun Pharmaceutical Industries, Ltd. (“Sun Pharma,” Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715). Taro will set a new record date for the rescheduled meetings and will mail a supplemental notice together with proxy materials to its shareholders.

Back to news